Management Co Llc Prospect, 10% Owner at Vitae Pharmaceuticals, Inc (VTAE), bought 933,784 shares at $8.00 ($5.4M) on 2014-09-29, disclosed to the SEC on 2014-10-01.
Open-market purchase of $5.4M VTAE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 261,977 | $0 | 0.0% |
| 2 | $8.00 | 671,807 | $5.4M | 100.0% |
| Total | $5.76 avg | 933,784 | $5.4M | 100% |